company background image
BLAU3 logo

Blau Farmacêutica BOVESPA:BLAU3 Stock Report

Last Price

R$13.77

Market Cap

R$2.4b

7D

-8.3%

1Y

-10.9%

Updated

02 Dec, 2024

Data

Company Financials +

Blau Farmacêutica S.A.

BOVESPA:BLAU3 Stock Report

Market Cap: R$2.4b

Blau Farmacêutica S.A. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Blau Farmacêutica
Historical stock prices
Current Share PriceR$13.77
52 Week HighR$17.61
52 Week LowR$9.20
Beta0.33
11 Month Change-6.64%
3 Month Change-4.11%
1 Year Change-10.93%
33 Year Change-61.54%
5 Year Changen/a
Change since IPO-66.50%

Recent News & Updates

Results: Blau Farmacêutica S.A. Exceeded Expectations And The Consensus Has Updated Its Estimates

Nov 07
Results: Blau Farmacêutica S.A. Exceeded Expectations And The Consensus Has Updated Its Estimates

Blau Farmacêutica S.A.'s (BVMF:BLAU3) 25% Share Price Surge Not Quite Adding Up

Nov 06
Blau Farmacêutica S.A.'s (BVMF:BLAU3) 25% Share Price Surge Not Quite Adding Up

Recent updates

Results: Blau Farmacêutica S.A. Exceeded Expectations And The Consensus Has Updated Its Estimates

Nov 07
Results: Blau Farmacêutica S.A. Exceeded Expectations And The Consensus Has Updated Its Estimates

Blau Farmacêutica S.A.'s (BVMF:BLAU3) 25% Share Price Surge Not Quite Adding Up

Nov 06
Blau Farmacêutica S.A.'s (BVMF:BLAU3) 25% Share Price Surge Not Quite Adding Up

Blau Farmacêutica S.A.'s (BVMF:BLAU3) 31% Price Boost Is Out Of Tune With Earnings

Aug 29
Blau Farmacêutica S.A.'s (BVMF:BLAU3) 31% Price Boost Is Out Of Tune With Earnings

Is Blau Farmacêutica (BVMF:BLAU3) A Risky Investment?

Jun 28
Is Blau Farmacêutica (BVMF:BLAU3) A Risky Investment?

Lacklustre Performance Is Driving Blau Farmacêutica S.A.'s (BVMF:BLAU3) 26% Price Drop

Feb 01
Lacklustre Performance Is Driving Blau Farmacêutica S.A.'s (BVMF:BLAU3) 26% Price Drop

What Does The Future Hold For Blau Farmacêutica S.A. (BVMF:BLAU3)? These Analysts Have Been Cutting Their Estimates

May 14
What Does The Future Hold For Blau Farmacêutica S.A. (BVMF:BLAU3)? These Analysts Have Been Cutting Their Estimates

Blau Farmacêutica S.A. Just Missed EPS By 18%: Here's What Analysts Think Will Happen Next

Feb 24
Blau Farmacêutica S.A. Just Missed EPS By 18%: Here's What Analysts Think Will Happen Next

Getting In Cheap On Blau Farmacêutica S.A. (BVMF:BLAU3) Is Unlikely

Oct 14
Getting In Cheap On Blau Farmacêutica S.A. (BVMF:BLAU3) Is Unlikely

Robust Earnings May Not Tell The Whole Story For Blau Farmacêutica (BVMF:BLAU3)

Aug 17
Robust Earnings May Not Tell The Whole Story For Blau Farmacêutica (BVMF:BLAU3)

Shareholder Returns

BLAU3BR BiotechsBR Market
7D-8.3%0.9%-3.0%
1Y-10.9%9.9%-4.9%

Return vs Industry: BLAU3 underperformed the BR Biotechs industry which returned 9.5% over the past year.

Return vs Market: BLAU3 underperformed the BR Market which returned -5.3% over the past year.

Price Volatility

Is BLAU3's price volatile compared to industry and market?
BLAU3 volatility
BLAU3 Average Weekly Movement7.3%
Biotechs Industry Average Movement9.1%
Market Average Movement4.8%
10% most volatile stocks in BR Market8.8%
10% least volatile stocks in BR Market2.4%

Stable Share Price: BLAU3's share price has been volatile over the past 3 months compared to the BR market.

Volatility Over Time: BLAU3's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of BR stocks.

About the Company

FoundedEmployeesCEOWebsite
19871,900Marcelo Hahnwww.blau.com

Blau Farmacêutica S.A., a pharmaceutical company provides high-complpexity drugs in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States. Its medications cover various segments, such as immunology, hematology, oncology, nephrology, infectious diseases, anesthesiology, and others. The company provides uterine stimulator; anesthetics; feminine health care; oncological products; antivirals and antiretrovirals; acid pump inhibitor; antithrombotic; antirheumatic; antibiotics; biopharmaceuticals; essential hospital products; biosimilars; hemoderivatives; and thrombolytics.

Blau Farmacêutica S.A. Fundamentals Summary

How do Blau Farmacêutica's earnings and revenue compare to its market cap?
BLAU3 fundamental statistics
Market capR$2.38b
Earnings (TTM)R$187.05m
Revenue (TTM)R$1.69b

13.1x

P/E Ratio

1.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BLAU3 income statement (TTM)
RevenueR$1.69b
Cost of RevenueR$1.09b
Gross ProfitR$596.47m
Other ExpensesR$409.43m
EarningsR$187.05m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.05
Gross Margin35.38%
Net Profit Margin11.10%
Debt/Equity Ratio24.5%

How did BLAU3 perform over the long term?

See historical performance and comparison

Dividends

5.4%

Current Dividend Yield

10%

Payout Ratio

Does BLAU3 pay a reliable dividends?

See BLAU3 dividend history and benchmarks
When do you need to buy BLAU3 by to receive an upcoming dividend?
Blau Farmacêutica dividend dates
Ex Dividend DateSep 27 2024
Dividend Pay DateDec 31 2024
Days until Ex dividend67 days
Days until Dividend pay date28 days

Does BLAU3 pay a reliable dividends?

See BLAU3 dividend history and benchmarks